Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1389426 New York, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,203,535
+$216,154 QoQ
Shares Held
66,092
-4.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 183 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. CGEM ranks #82 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6 APGE
Apogee Therapeutics, Inc.
 33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in CGEM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,203,535 66,092
2026-03-31 $987,381 69,485
2025-12-31 $638,294 61,671
2025-09-30 $241,522 40,729
2025-06-30 $295,371 39,226
2025-03-31 $415,910 54,942
2024-12-31 $1,092,034 89,658
2024-09-30 $1,919,575 114,670
2024-06-30 $1,825,113 104,651
2024-03-31 $1,653,817 97,055
2022-03-31 $577,441 55,152
2021-12-31 $1,097,674 71,139